Evaluation of D2 and D3 dopamine receptor selective compounds on l-dopa-dependent abnormal involuntary movements in rats

Medicine & Life Sciences

• Dopamine D3 Receptors 100%
• Dihydroxyphenylalanine 90%
• Dopamine D2 Receptors 82%
• Dyskinesias 77%
• 1-((5-methoxy-1H-indol-3-yl)methyl)-4-(4-(methylthio)phenyl)piperidin-4-ol 9%
• Oxidopamine 8%
• Dopamine Agonists 8%
• phenylpiperazine 6%
• SK&F 81297 6%
• Parkinson Disease 6%
• Benserazide 6%
• Dopamine D2 Receptor Antagonists 5%
• Buspirone 5%
• Receptor, Serotonin, 5-HT1A 4%
• Bromocriptine 4%
• Dopamine Antagonists 4%
• Forelimb 4%
• Colforsin 4%
• HEK293 Cells 4%
• Adenylyl Cyclases 3%
• Animals 3%
• Locomotion 3%
• Sprague Dawley Rats 3%
• Animal Models 2%
• Therapeutics 1%